Single-Cell Genomics Market Size, Report by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Single-Cell Genomics Market

5.1. COVID-19 Landscape: Single-Cell Genomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Single-Cell Genomics Market, By Product and Service

8.1. Single-Cell Genomics Market, by Product and Service

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast

8.1.3. Software and Bioinformatics Tools

8.1.3.1. Market Revenue and Forecast

8.1.4. Services

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Single-Cell Genomics Market, By Technology

9.1. Single-Cell Genomics Market, by Technology

9.1.1. Single-Cell RNA Sequencing (scRNA-seq)

9.1.1.1. Market Revenue and Forecast

9.1.2. Whole Genome Sequencing (WGS)

9.1.2.1. Market Revenue and Forecast

9.1.3. Whole Exome Sequencing (WES)

9.1.3.1. Market Revenue and Forecast

9.1.4. DNA Methylation and Epigenomics

9.1.4.1. Market Revenue and Forecast

9.1.5. Single-Cell Multi-omics

9.1.5.1. Market Revenue and Forecast

9.1.6. Single-Cell Proteomics

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Single-Cell Genomics Market, By Workflow

10.1. Single-Cell Genomics Market, by Workflow

10.1.1. Sample Preparation

10.1.1.1. Market Revenue and Forecast

10.1.2. Isolation and Sorting

10.1.2.1. Market Revenue and Forecast

10.1.3. Genomic Sequencing

10.1.3.1. Market Revenue and Forecast

10.1.4. Data Analysis and Interpretation

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Single-Cell Genomics Market, By Application

11.1. Single-Cell Genomics Market, by Application

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast

11.1.2. Immunology

11.1.2.1. Market Revenue and Forecast

11.1.3. Neurology

11.1.3.1. Market Revenue and Forecast

11.1.4. Stem Cell Research

11.1.4.1. Market Revenue and Forecast

11.1.5. Developmental Biology

11.1.5.1. Market Revenue and Forecast

11.1.6. Infectious Diseases

11.1.6.1. Market Revenue and Forecast

11.1.7. Others

11.1.7.1. Market Revenue and Forecast

Chapter 12. Global Single-Cell Genomics Market, By End User

12.1. Single-Cell Genomics Market, by End User

12.1.1. Academic and Research Institutes

12.1.1.1. Market Revenue and Forecast

12.1.2. Pharmaceutical and Biotechnology Companies

12.1.2.1. Market Revenue and Forecast

12.1.3. Clinical and Translational Research Centers

12.1.3.1. Market Revenue and Forecast

12.1.4. Contract Research Organizations (CROs)

12.1.4.1. Market Revenue and Forecast

12.1.5. Diagnostic Laboratories

12.1.5.1. Market Revenue and Forecast

12.1.6. Others

12.1.6.1. Market Revenue and Forecast

Chapter 13. Global Single-Cell Genomics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product and Service

13.1.2. Market Revenue and Forecast, by Technology

13.1.3. Market Revenue and Forecast, by Workflow

13.1.4. Market Revenue and Forecast, by Application

13.1.5. Market Revenue and Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product and Service

13.1.6.2. Market Revenue and Forecast, by Technology

13.1.6.3. Market Revenue and Forecast, by Workflow

13.1.6.4. Market Revenue and Forecast, by Application

13.1.6.5. Market Revenue and Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product and Service

13.1.7.2. Market Revenue and Forecast, by Technology

13.1.7.3. Market Revenue and Forecast, by Workflow

13.1.7.4. Market Revenue and Forecast, by Application

13.1.7.5. Market Revenue and Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product and Service

13.2.2. Market Revenue and Forecast, by Technology

13.2.3. Market Revenue and Forecast, by Workflow

13.2.4. Market Revenue and Forecast, by Application

13.2.5. Market Revenue and Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product and Service

13.2.6.2. Market Revenue and Forecast, by Technology

13.2.6.3. Market Revenue and Forecast, by Workflow

13.2.7. Market Revenue and Forecast, by Application

13.2.8. Market Revenue and Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product and Service

13.2.9.2. Market Revenue and Forecast, by Technology

13.2.9.3. Market Revenue and Forecast, by Workflow

13.2.10. Market Revenue and Forecast, by Application

13.2.11. Market Revenue and Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product and Service

13.2.12.2. Market Revenue and Forecast, by Technology

13.2.12.3. Market Revenue and Forecast, by Workflow

13.2.12.4. Market Revenue and Forecast, by Application

13.2.13. Market Revenue and Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product and Service

13.2.14.2. Market Revenue and Forecast, by Technology

13.2.14.3. Market Revenue and Forecast, by Workflow

13.2.14.4. Market Revenue and Forecast, by Application

13.2.15. Market Revenue and Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product and Service

13.3.2. Market Revenue and Forecast, by Technology

13.3.3. Market Revenue and Forecast, by Workflow

13.3.4. Market Revenue and Forecast, by Application

13.3.5. Market Revenue and Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product and Service

13.3.6.2. Market Revenue and Forecast, by Technology

13.3.6.3. Market Revenue and Forecast, by Workflow

13.3.6.4. Market Revenue and Forecast, by Application

13.3.7. Market Revenue and Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product and Service

13.3.8.2. Market Revenue and Forecast, by Technology

13.3.8.3. Market Revenue and Forecast, by Workflow

13.3.8.4. Market Revenue and Forecast, by Application

13.3.9. Market Revenue and Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product and Service

13.3.10.2. Market Revenue and Forecast, by Technology

13.3.10.3. Market Revenue and Forecast, by Workflow

13.3.10.4. Market Revenue and Forecast, by Application

13.3.10.5. Market Revenue and Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product and Service

13.3.11.2. Market Revenue and Forecast, by Technology

13.3.11.3. Market Revenue and Forecast, by Workflow

13.3.11.4. Market Revenue and Forecast, by Application

13.3.11.5. Market Revenue and Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product and Service

13.4.2. Market Revenue and Forecast, by Technology

13.4.3. Market Revenue and Forecast, by Workflow

13.4.4. Market Revenue and Forecast, by Application

13.4.5. Market Revenue and Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product and Service

13.4.6.2. Market Revenue and Forecast, by Technology

13.4.6.3. Market Revenue and Forecast, by Workflow

13.4.6.4. Market Revenue and Forecast, by Application

13.4.7. Market Revenue and Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product and Service

13.4.8.2. Market Revenue and Forecast, by Technology

13.4.8.3. Market Revenue and Forecast, by Workflow

13.4.8.4. Market Revenue and Forecast, by Application

13.4.9. Market Revenue and Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product and Service

13.4.10.2. Market Revenue and Forecast, by Technology

13.4.10.3. Market Revenue and Forecast, by Workflow

13.4.10.4. Market Revenue and Forecast, by Application

13.4.10.5. Market Revenue and Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product and Service

13.4.11.2. Market Revenue and Forecast, by Technology

13.4.11.3. Market Revenue and Forecast, by Workflow

13.4.11.4. Market Revenue and Forecast, by Application

13.4.11.5. Market Revenue and Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product and Service

13.5.2. Market Revenue and Forecast, by Technology

13.5.3. Market Revenue and Forecast, by Workflow

13.5.4. Market Revenue and Forecast, by Application

13.5.5. Market Revenue and Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product and Service

13.5.6.2. Market Revenue and Forecast, by Technology

13.5.6.3. Market Revenue and Forecast, by Workflow

13.5.6.4. Market Revenue and Forecast, by Application

13.5.7. Market Revenue and Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product and Service

13.5.8.2. Market Revenue and Forecast, by Technology

13.5.8.3. Market Revenue and Forecast, by Workflow

13.5.8.4. Market Revenue and Forecast, by Application

13.5.8.5. Market Revenue and Forecast, by End User

Chapter 14. Company Profiles

14.1. 10x Genomics

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Illumina, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Abbott

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Fluidigm Corporation (Standard BioTools)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bio-Rad Laboratories, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Thermo Fisher Scientific Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. BGI Genomics Co., Ltd.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Takara Bio, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Mission Bio, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. NanoString Technologies, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the single-cell genomics market include 10x Genomics, Illumina, Inc., Fluidigm Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., Takara Bio, Inc., Mission Bio, Inc., NanoString Technologies, Inc., QIAGEN N.V., Oxford Nanopore Technologies, PerkinElmer, Inc., Roche Sequencing Solutions, Agilent Technologies, Inc., Dolomite Bio, Zymo Research Corporation, SeqWell, Inc., Parse Biosciences, Novogene Corporation, and Singleron Biotechnologies.

The driving factors of the single-cell genomics market are the advancements in sequencing technologies, rising applications in precision medicine, and expanding research in complex disease biology.

North America region will lead the global single-cell genomics market during the forecast period 2025 to 2034.